Showing results (351-360 of 1,361) with videos related to
Sort By:
Pageof 137
Drugs Under Experimental and Clinical Research|January 1, 1990
Peripheral red blood cell survival invariance during pefloxacin treatment in subjects with glucose-6-phosphate dehydrogenase deficiencyG Perpignano, Q Mela, V Ruggiero, et al.Drugs Under Experimental and Clinical Research|January 1, 1990
Streptococcal pharyngitis in Italian children: epidemiology and treatment with miocamycinN Principi, P Marchisio, A Calanchi, et al.Drugs Under Experimental and Clinical Research|January 1, 1989
The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compoundI Wiesenberg-Boettcher, A Schweizer, J R Green, et al.Drugs Under Experimental and Clinical Research|January 1, 1989
Comparative in vitro activity of ciprofloxacin and other unrelated antimicrobials against bacterial respiratory tract pathogensD Felmingham, M J Robbins, A J Baskerville, et al.Drugs Under Experimental and Clinical Research|January 1, 1989
Cefroxadine in the treatment of children affected by respiratory and ENT diseases. A multicentre study involving 1072 in-patientsF Scaglione, G Cattaneo, M M Bianchi, et al.Drugs Under Experimental and Clinical Research|January 1, 1986
Peplomycin therapy for skin cancer in JapanS Ikeda, K Ishihara, N MatsunakaDrugs Under Experimental and Clinical Research|January 1, 1989
Pharmacological evaluation of five novel dexamethasone heneicosoic (21) acid derivativesS U Hong, K H Park, J S Chae, et al.Drugs Under Experimental and Clinical Research|January 1, 1987
Effects of short- and long-term administrations of famotidine and ranitidine on some pituitary, sexual and thyroid hormonesR Corinaldesi, R Pasquali, A Paternico, et al.Drugs Under Experimental and Clinical Research|January 1, 1987
Action of famotidine and ranitidine on prostaglandin E2 (PGE2) content of fundic and duodenal mucosa in duodenal ulcer patientsE Lezoche, V Vagni, M D D'Alessandro, et al.Drugs Under Experimental and Clinical Research|January 1, 1989
Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosisD Agnusdei, F Zacchei, S Bigazzi, et al.Pageof 137